Pharmacological characterization of the discriminative stimulus properties of the phencyclidine analog, N-[1-(2-benzo(b)thiophenyl)- cyclohexyl]piperidine

Psychopharmacology

Volumn 145, Issue 4, 1999, Pages 370-377

  Kleven, Mark S ^a   Kamenka, Jean Marc ^b   Vignon, Jacques ^c   Koek, Wouter ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b CNRS   (France)

^c INSERM   (France)

Author keywords

BTCP; Cocaine; Dopamine; Drug discrimination; Monoamine re uptake blocker; Norepinephrine; Prazosin

Indexed keywords

1 [1 (2 BENZO[B]THIENYL)CYCLOHEXYL]PIPERIDINE; 1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLALLYL)PIPERAZINE; 1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; CAFFEINE; CHLORPHENIRAMINE; COCAINE; DESIPRAMINE; DIAZEPAM; DIZOCILPINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; INDATRALINE; MAZINDOL; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; NISOXETINE; NORTRIPTYLINE; PAROXETINE; PHENCYCLIDINE; PHENCYCLIDINE DERIVATIVE; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DISCRIMINATION; DRUG MECHANISM; DRUG POTENCY; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; COCAINE; DISCRIMINATION LEARNING; DOPAMINE UPTAKE INHIBITORS; MALE; NOREPINEPHRINE; PHENCYCLIDINE; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS;

EID: 0032879429     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051070     Document Type: Article

References (40)

1. Akunne HC, Dersch CM, Cadet JL, Baumann MH, Char GU, Partilla JS, de Costa BR, Rice KC, Carroll FI, Rothman RB (1994) Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes. J Pharmacol Exp Ther 268:1462-1475
2. Baker LE, Riddle EE, Saunders RB, Appel JB (1993) The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4:69-79
3. Broadbent J, Michael EK, Riddle EE, Appel JB (1991) Involvement of dopamine uptake in the discriminative stimulus effects of cocaine. Behav Pharmacol 2:187-197
4. Chergui K, Akaoka H, Brunei J-L, Charlety PJ, Saunier CF, Buda M, Privat A, Vignon J, Kamenka J-M, Chouvet G (1992) Inhibition of locus coeruleus neurons by the phencyclidine analog, N-[1-(2-benzo(b)thiophenyl)cycclohexyyl]piperidine (BTCP): evidence for potent indirect noradrenergic agonist properties. Eur J Pharmacol 219:169-172
5. Colpaert FC, Niemegeers CJE, Janssen PAJ (1979) Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol Biochem Behav 10:535-546
6. Cunningham KA, Callahan PM (1991) Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology 104:177-180
7. de la Garza R, Johanson CE (1983) The discriminative stimulus properties of cocaine in the rhesus monkey. Pharmacol Biochem Behav 19:145-148
8. Durazzo TC, Gauvin DV, Goulden KL, Briscoe RJ, Holloway FA (1994) Technical report: the subcutaneous administration of cocaine in the rat. Pharmacol Biochem Behav 49:1007-1010
9. Duterte-Boucher D, Vaugeois J-M, Costentin J, Ilagouma A, Maurice T, Vignon J, Kamenka J-M (1992) In vivo and in vitro effects of BTCP and derivatives related to dopamine and norepinephrine neuronal uptake inhibition. In: Kamenka J-M, Domino EF (eds) Multiple sigma and PCP receptor ligands. NPP Books, Ann Arbor, MI, pp 435-443
10. Gauvin DV, Harland RD, Michaelis RC, Holloway FA (1989) Caffeine-phenylethylamine combinations mimic the cocaine discriminative cue. Life Sci 44:67-73
11. Gauvin DV, Criado JR, Moore KR, Holloway FA (1990) Potentiation of cocaine's discriminative effects by caffeine: a time-effect analysis. Pharmacol Biochem Behav 36:195-197
12. Gauvin DV, Carl KL, Briscoe RJ, Vallet M, Holloway FA (1995) Cross-generalization between a cocaine cue and two antihistamines. Eur J Pharmacol 294:281-288
13. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612
14. Hubert JJ (1984) Bioassay. Kendall/Hunt, Dubuque, Iowa
15. Ilagouma AT, Maurice T, Duterte-Boucher D, Coderc E, Vignon J, Costentin J, Kamenka JM (1993) Arylcyclohexylamines derived from BTCP are potent indirect catecholamine agonists. Eur J Med Chem 28:377-385
16. Izenwasser S, Werling LL, Cox BM (1990) Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Res 520:303-309
17. Katz JL, Newman AH, Izenwasser S (1997) Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine. Pharmacol Biochem Behav 57:505-512
18. Kleven MS, Koek W (1997) Discriminative stimulus properties of cocaine: enhancement by β-adrenergic receptor antagonists. Psychopharmacology 131:307-312
19. Kleven MS, Koek W (1998) Discriminative stimulus properties of cocaine: enhancement by monoamine reuptake blockers. J Pharmacol Exp Ther 284:1015-1025
20. Kleven MS, Anthony EW, Woolverton WL (1990) Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 254: 312-317
21. Kleven MS, Assié MB, Koek W (1997) Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. J Pharmacol Exp Ther 282:747-759
22. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199:649-661
23. Koek W, Colpaert FC, Woods JH, Kamenka JM (1989) The phencyclidine (PCP) analog N-(1-(2-benzo(B)thiophenyl) cyclohexyl) piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801. J Pharmacol Exp Ther 250:1019-1027
24. Koek W, Kleven MS, Colpaert FC (1995) Effects of the NMDA antagonist, dizocilpine, in various drug discriminations: characterization of intermediate levels of drug lever selection. Behav Pharmacol 6:590-600
25. Lebel LA, Nowakowski JT, Macor JE, Fox CB, Koe BK (1994) Dopamine uptake inhibitory activity of novel tryptamine 5-HT1 receptor ligands. Drug Dev Res 33:413-421
26. Maurice T, Vignon J, Kamenka J-M, Chicheportiche R (1989) In vivo labelling of the mouse dopamine uptake complex with the phencyclidine derivative [3H]BTCP. Neurosci Lett 101: 234-238
27. Prinssen EPM, Kleven MS, Vignon J, Kamenka J-M, Koek W (1996) Effects of repeated administration of N-[1-(2-benzo(b)-thiophenyl)cycloheyyl]piperidine and cocaine on locomotor activity in C57BL/6 mice. J Pharmacol Exp Ther 276:904-911
28. Prinssen EPM, Koek W, Vignon J, Kamenka J-M, Kleven MS (1999) Does crossing over repeated administration with the dopmaine reuptake inhibitors cocaine and BTCP modify their effects on cocaine-induced locomotion? Psychopharmacology 143:8-14
29. Rothman RB, Lewis B, Dersch C, Xu H, Radesca L, de Costa BR, Rice KC, Kilburn RB, Akunne HC, Pert A (1993) Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters. Synapse 14:34-39
30. Saadouni S, Refahi-Lyamani F, Costentin J, Bonnet J-J (1994) Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier. Eur J Pharmacol 268:187-197
31. Schuster CR, Fischman MW, Johanson CE (1981) Internal stimulus control and the subjective effects of drugs. NIDA Res Monogr 37:116-129
32. Silvia CP, Jaber M, King GR, Ellinwood EH, Caron MG (1997) Cocaine and amphetamine elicit differential effects in rats with a unilateral injection of dopamine transporter antisense oligodeoxynucleotides. Neuroscience 76:737-747
33. Slifer BL (1988) CNS stimulant-like discriminative stimulus properties of H1-antagonists in rats. Psychopharmacology 96:S53
34. Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 112:93-99
35. Spealman RD (1995) Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 275:53-62
36. Stanford SC (1996) Prozac: panacea or puzzle? Trends Pharmacol Sci 17:150-154
37. Suzuki T, Mori T, Misawa M, Onodera K (1997) Generalization of D-, L-and DL-chlorpheniramine and zolantidine to the discriminative stimulus effects of cocaine and methamphetamine. Behav Pharmacol 8:718-724
38. Tallarida RJ, Murray RB (1987) Manual of pharmacological calculations with computer programs. Springer, Berlin Heidelberg New York
39. Terry P, Witkin JM, Katz JL (1994) Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. J Pharmacol Exp Ther 270:1041-1048
40. Vignon J, Pinet V, Cerruti C, Kamenka J-M, Chicheportiche R (1988) [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3]BTCP): a new phencyclidine analog selective for the dopamine uptake complex. Eur J Pharmacol 148:427-436